Eureka projects

Optimed will develop an innovative intraoral drug delivery system. The system is aimed at reaching stabilized and adjustable circulating l-dopa levels in parkinson’s disease patients, thus maximizing symptomatic benefit and minimizing motor complications and medication side-effects.
Project ID: 

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.